In one of the most anxiously awaited court decisions of the year, the US Supreme Court today unanimously struck down patents on isolated, natural human genes.
Patents on synthesized DNA, however, are still valid, the justices said. Included in that category are commercially important patents on cDNA — segments of DNA synthesized using an RNA template.
This is good news for basic research and for the public in general. To read more, click here.